Publicaciones (19) Publicaciones de María Marcos Jubilar

2024

  1. Factor XI inhibitors: A new era in antithrombotic therapy

    Medicina Clinica

2023

  1. Analysis of common biomarkers in capillary blood in routine clinical laboratory. Preanalytical and analytical comparison with venous blood

    Diagnosis, Vol. 10, Núm. 3, pp. 281-297

  2. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

2022

  1. 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

  2. Impact of the mutation profile on thrombotic risk in cancer patients

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 93-99

  3. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC

    Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10

  4. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

  5. Thromboprophylaxis in Patients With Cancer and COVID-19

    Archivos de Bronconeumologia

2021

  1. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

2020

  1. Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers

    Cancers, Vol. 12, Núm. 4

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  4. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications

    Transfusion Medicine, Vol. 29, Núm. 4, pp. 268-274

2016

  1. Obinutuzumab in follicular lymphoma

    Drugs of Today, Vol. 52, Núm. 12, pp. 643-651

2014

  1. Seguridad y eficacia de un concentrado de complejo protrombínico en pacientes con coagulopatía y hemorragia

    Anales del sistema sanitario de Navarra, Vol. 37, Núm. 3, pp. 363-369

2001

  1. Factores pronósticos del carcinoma gástrico

    Anales del sistema sanitario de Navarra, Vol. 24, Núm. 1, pp. 111-120

  2. Factores pronósticos en los tumores cerebrales

    Anales del sistema sanitario de Navarra, Vol. 24, Núm. 1, pp. 63-72

  3. Factores pronósticos en los tumores de origen ginecológico

    Anales del sistema sanitario de Navarra, Vol. 24, Núm. 1, pp. 121-132